Azathioprine in paediatric inflammatory bowel disease: An italian multicentre survey

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 6, 2002, Pages 1125-1130

  Barabino, A ^a   Torrente, F ^b   Ventura, A ^c   Cucchiara, S ^d   Castro, M ^e   Barbera, C ^f  

^a G GASLINI INSTITUTE   (Italy)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TRIESTE   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENTERITIS; FEMALE; HEALTH SURVEY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PEDIATRICS; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SIDE EFFECT; HOSPITALIZATION; INFANT; PATHOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; AZATHIOPRINE; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH SURVEYS; HUMAN; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFLAMMATORY BOWEL DISEASES; ITALY; MALE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; HUMANS;

EID: 0035999146     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01269.x     Document Type: Article

References (25)

1. Azathioprine: State of the art in inflammatory bowel disease
2. Review article: The treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine
3. Azathioprine in the treatment of children with inflammatory bowel disease
4. Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease
5. Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis
6. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease
7. Immunosuppressive therapy in pediatric inflammatory bowel disease: Results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition
8. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease
9. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
10. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease
11. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
12. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease
13. Treatment of Crohn's disease with azathioprine or 6-mercaptopurine. Retrospective study of 126 cases
14. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience
15. The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease
16. Rational dosing of azathioprine and 6-mercaptopurine
17. 6-Mercaptopurine metabolism in Crohn's disease: Correlation with efficacy and toxicity
18. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease
19. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
20. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease
21. Extraintestinal cancers in inflammatory bowel disease
22. Lymphoma in inflammatory bowel disease
23. Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease
24. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease
25. Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma